Vietnam Professional Acne Medication Market

Customize Now
Vietnam Professional Acne Medication Market

Vietnam Professional Acne Medication Market By Acne Type (Inflammatory Acne, Non-Inflammatory Acne), By Formulation (Topical Medications, Combination Treatments and Others), By Acne Severity (Mild, Moderate, Severe, Post-Inflammatory Hyperpigmentation), By Distribution Channel (Dermatologist & Aesthetician, Pharmacies & Drug Stores and Others), By End User (Dermatology Clinics, Hospitals & Healthcare Facilities and Others) – Analysis & Forecast, 2025–2035

Industry: Healthcare | Lastest Edition: May 7, 2026 | No of Pages: 203 | No. of Tables: 85 | No. of Figures: 74 | Format: PDF | Report Code : HC1130

Industry Outlook

The Vietnam Professional Acne Medication Market size was valued at USD 46.48 million in 2025 and is expected to reach USD 53.61 million by 2026. Looking ahead, the industry is projected to expand rapidly, reaching USD 122.89 million by 2035, registering a CAGR of 9.66% from 2026 to 2035.

The Vietnam professional acne medication market is in a formative stage, shaped by rapid urbanisation, changing lifestyles, and rising awareness of dermatological health. Acne prevalence is increasing among adolescents and young adults, driven by pollution exposure, dietary shifts, and stress associated with fast-paced urban living. Professional treatment adoption is strongest in major cities, where private dermatology clinics and hospitals are expanding, and patients are more willing to seek specialist care after limited success with over-the-counter products. Prescription therapies are typically used for inflammatory or persistent acne, alongside basic skincare guidance rather than intensive procedural intervention. Market development is influenced by affordability, uneven specialist access, and evolving regulatory frameworks, which moderate the pace of expansion. Despite these constraints, improving healthcare access and growing interest in clinician-led skin treatment are gradually strengthening Vietnam’s professional acne medication market.

 

Youthful Demographics and Rapidly Changing Urban Habits Drive Vietnam Professional Acne Medication Market Growth

The professional acne medication market in Vietnam is being shaped by a young population and rapidly evolving urban lifestyles. Vietnam’s cities are experiencing increased exposure to pollution, humidity, irregular diets, and work–study pressure, all of which contribute to rising acne incidence among teenagers and young adults. Clear skin is increasingly associated with confidence, employability, and social presence, particularly in urban centres. As awareness grows about acne-related scarring and pigmentation, consumers are becoming more open to dermatologist-guided treatments rather than relying solely on traditional or cosmetic remedies. This behavioural shift is gradually expanding the acceptance of prescription-grade acne medications, especially among digitally connected youth who actively seek credible and long-term solutions.

Growing Private Healthcare and Dermatology Awareness Drives Market Growth

Expansion of private healthcare services is playing a central role in strengthening Vietnam’s professional acne medication market. Private hospitals, dermatology clinics, and aesthetic centres are increasing in number, particularly in major cities, offering specialised skin treatments and quicker access to care. Dermatologists are increasingly trusted for accurate diagnosis and structured acne management plans, which boosts prescription rates. In parallel, rising health awareness through online platforms and clinic-led education is helping consumers differentiate between cosmetic skincare and medical treatment. Improved availability of trained specialists and modern treatment protocols is creating a more supportive ecosystem for professional acne medications, driving gradual but steady market growth.

Cost Sensitivity and Reliance on Non-Prescription Solutions Limits Market Growth

A key restraint in Vietnam’s professional acne medication market is strong price sensitivity combined with reliance on non-prescription alternatives. Many consumers initially opt for over-the-counter products, herbal remedies, or informal advice due to lower costs and cultural familiarity. Professional acne treatments require sustained use and follow-up visits, which be perceived as financially demanding, especially among students and early-career professionals. This leads to delayed medical consultation and inconsistent treatment adherence. As a result, prescription medications are more commonly adopted for moderate-to-severe cases, limiting broader penetration and slowing overall market expansion.

Affordable, Education-Led Acne Care Models Creates Vietnam Professional Acne Medication Market Opportunities

Vietnam offers strong growth potential through affordable and education-focused acne treatment strategies. Cost-effective formulations, simplified regimens, and flexible pricing significantly improve access for younger populations. Increased patient education, both online and in clinics, encourages earlier intervention and better adherence. Tele-dermatology and digital follow-ups also present opportunities to extend specialist care beyond major cities. As consumers become more informed about the long-term benefits of professional treatment, acne medications that balance affordability, effectiveness, and accessibility are well-positioned to drive sustained growth in Vietnam’s evolving dermatology market.

Competitive Landscape

The Vietnam professional acne medication industry comprises various market players, such as Bayer AG, Pfizer Inc., GlaxoSmithKline group of companies, Pfizer Inc., F. Hoffmann-La Roche, Galderma, Vinapharco, BEIERSDORF, Dermafirm, MD CARE CO., LTD., Bioderma, Bo International Pvt. Ltd., Glenmark Pharmaceuticals Ltd., Kenvue Inc., Rixin Cosmetics Co., Ltd and others. 

 

Vietnam Professional Acne Medication Market Key Segments

By Acne Type

  • Inflammatory Acne

    • Papules & Pustules

    • Nodules

    • Cystic Acne

  • Non-Inflammatory Acne

    • Open Comedones

    • Closed Comedones

By Formulation

  • Topical Medications

    • Gels

    • Creams

    • Lotions

    • Other Tropical Medications

  • Combination Treatments

  • Laser and Light-Based Treatments

    • Blue Light Therapy

    • Intense Pulsed Light

    • Photodynamic Therapy

  • Oral Medications

    • Tablets

    • Capsules

    • Oral Suspensions

By Acne Severity

  • Mild Acne

  • Moderate Acne

  • Severe Acne

  • Post-Inflammatory Hyperpigmentation (Pih)

By Skin Type

  • Normal/Combination Skin

  • Dry Skin

  • Oily Skin

  • Sensitive Skin        

By Age Group

  • Pediatric Patients (≤12 years)

  • Teenagers and Young Adults (13-30 years)

  • Adults (31 years and Above)

By Therapeutic Class

  • Retinoids

  • Antibiotics

  • Salicylic Acid

  • Benzoyl Peroxide

  • Others

By Price Tier

  • Low Price Tier

  • Mid Price Tier

  • High Price Tier

By Treatment Setting

  • In-Clinic / In-Office Treatment

  • At-Home Treatment

  • Hybrid Treatment Model

By Application

  • Facial Acne Treatment

  • Body Acne Treatment

  • Scalp Acne Treatment

By Distribution Channel

  • Dermatologist & Aesthetician

  • Pharmacies & drug store

  • E-Commerce

  • Others

By End User

  • Dermatology Clinics

  • Hospitals & Healthcare Facilities

  • Medical Spas

  • Cosmetic Surgeons

  • Pharmacies / Chemists

  • Teledermatology Services

  • Other End Users

Key Players

  • Bayer AG

  • Pfizer Inc.

  • GlaxoSmithKline group of companies

  • Pfizer Inc

  • F. Hoffmann-La Roche

  • Galderma

  • Vinapharco

  • BEIERSDORF

  • Dermafirm

  • Tu Hao Flagship Store

  • Bioderma

  • Bo International Pvt. Ltd.

  • Glenmark Pharmaceuticals Ltd

  • Kenvue Inc.

  • Rixin Cosmetics Co., Ltd.

Report Scope and Segmentation:

Parameters

Details

Market Size in 2026

USD 53.61 Million

Revenue Forecast in 2035

USD 122.89 Million

Growth Rate

CAGR of 9.66% from 2026 to 2035

Analysis Period

2025–2035

Base Year Considered

2025

Forecast Period

2026–2035

Market Size Estimation

Million (USD)

Growth Factors

  • Youthful Demographics and Fast-Changing Urban Habits

  • Growing Private Healthcare and Dermatology Awareness

Companies Profiled

15

Market Share

Available for 10 companies

Customization Scope

Free customization (equivalent to up to 80 analyst-working hours) after purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options

Avail customized purchase options to meet your exact research needs.

Approach

In-depth primary and secondary research; proprietary databases; rigorous quality control and validation measures.

Analytical Tools

Porter's Five Forces, SWOT, value chain, and Harvey ball analysis to assess competitive intensity, stakeholder roles, and relative impact of key factors.

Vietnam Professional Acne Medication Market Revenue by 2030 (Billion USD) Vietnam Professional Acne Medication Market Segmentation

About the Author

Saista Faiyaz is a Research Associate specializing in analytical research, structured data review, and knowledge-driven insight development. She supports projects through methodical evaluation, cross-disciplinary understanding, and clear documentation that aid informed outcomes. With experience bridging research and technical domains, she contributes to organized learning processes, critical analysis, and collaborative problem solving. Her approach emphasizes accuracy, adaptability, and clarity, enabling consistent research support and meaningful contributions across diverse projects effectively.

About the Reviewer

Supradip Baul is an accomplished business consultant and strategist with over a decade of rich experience in market intelligence, strategy, technology, and business transformation. His work has included rigorous qualitative and quantitative analysis across multiple industries, helping clients shape investment decisions and long-term roadmaps. Earlier in his career, he was associated with Gartner, where he contributed to industry-leading reports and market share analyses. He has worked with leading global companies and holds an MBA with a dual specialization in Marketing and Finance.

Download Free Sample

Please Enter Full Name

Please Enter Valid Email ID

Please enter Country Code and Phone No

Please enter message

Frequently Asked Questions

The key market players operating in the Vietnam professional acne medication market are Bayer AG, Pfizer Inc., GlaxoSmithKline group of companies, and others.

According to the report published by Next Move Strategy Consulting, Vietnam professional acne medication market is valued at USD 53.61 Million in 2026.

According to Next Move Strategy Consulting, the market size is estimated to be USD 122.89 Million by 2035.

Vietnam is moving from informal treatment habits toward dermatologist-guided care as awareness of chronic acne management steadily improves.

Prescribing remains cautious and value-driven, with physicians emphasizing practical efficacy and patient affordability to build long-term treatment adherence.

This website uses cookies to ensure you get the best experience on our website. Learn more